This all spells bad news for the makers of Acomplia/Zimulti. In their most recent attempt at approval, the FDA denied the sale of the drug within the United States citing the need for additional testing and a better understanding of long term side effects. This denial has left some saying that Acomplia won’t be passed by the FDA until at least 2010. If Merck and Pfizer are able to get their own products passed before then, then they will undoubtedly have earned the dominant market share by that time.

The very thing that makes Acomplia work, its ability to alter the operation of neuro- sensors, is what makes it so dangerous. Stories of suicidally severe depression are rampant on the internet and from consumer watchdog groups. Whether or not Acomplia helps people to lose weight is not in question. The questions all circle around how healthy it is for you overall, and the question of mental health is as important in this discussion as is physical. Until these questions are addressed, the future isn’t shining very brightly for Acomplia in the United States.

Page 2 of 2 :: First | Last :: Prev | 1 2 | Next